Herbert Barton Grossman
Overview
Explore the profile of Herbert Barton Grossman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
173
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fleshner N, Grossman H, Berglund R, Hafron J, Inman B, Karsh L, et al.
Bladder Cancer
. 2025 Mar;
10(4):278-289.
PMID: 40035078
Background: Bladder EpiCheck (BE) is a novel methylation-based PCR urine test for the detection of non-muscle invasive bladder cancer (NMIBC) recurrences. Objective: We present the results of a North American...
2.
Bree K, Hensley P, Brooks N, Matulay J, Li R, Nogueras Gonzalez G, et al.
BJU Int
. 2021 Jan;
128(5):568-574.
PMID: 33484074
Objective: To evaluate the impact of upper tract urothelial carcinoma (UTUC) on bacillus Calmette-Guerin (BCG) response and progression in patients with non-muscle-invasive bladder cancer (NMIBC). Patients And Methods: We performed...
3.
Follow-up in non-muscle-invasive bladder cancer-International Bladder Cancer Network recommendations
Kassouf W, Traboulsi S, Schmitz-Drager B, Palou J, Witjes J, van Rhijn B, et al.
Urol Oncol
. 2016 Jul;
34(10):460-8.
PMID: 27368880
Objective: Non-muscle-invasive bladder cancer (NMIBC) comprises a wide spectrum of tumors with different behaviors and prognoses. It follows that the surveillance for these tumors should be adapted according to the...
4.
Earl J, Rico D, Carrillo-de-Santa-Pau E, Rodriguez-Santiago B, Mendez-Pertuz M, Auer H, et al.
BMC Genomics
. 2015 May;
16:403.
PMID: 25997541
Background: Urothelial bladder cancer is a highly heterogeneous disease. Cancer cell lines are useful tools for its study. This is a comprehensive genomic characterization of 40 urothelial bladder carcinoma (UBC)...
5.
Apolo A, Grossman H, Bajorin D, Steinberg G, Kamat A
Urol Oncol
. 2012 Dec;
30(6):772-80.
PMID: 23218068
At the 11th annual meeting of the Society of Urologic Oncology, an expert panel was convened to discuss the practical use of perioperative chemotherapy for muscle-invasive bladder cancer. The discussion...
6.
Majewski T, Spiess P, Bondaruk J, Black P, Clarke C, Benedict W, et al.
PLoS One
. 2012 Aug;
7(8):e42452.
PMID: 22879988
We used protein expression profiles to develop a classification rule for the detection and prognostic assessment of bladder cancer in voided urine samples. Using the Ciphergen PBS II ProteinChip Reader,...
7.
Lee S, Jeong J, Majewski T, Scherer S, Kim M, Tuziak T, et al.
Proc Natl Acad Sci U S A
. 2007 Aug;
104(34):13732-7.
PMID: 17702869
We used human bladder cancer as a model system and the whole-organ histologic and genetic mapping strategy to identify clonal genetic hits associated with growth advantage, tracking the evolution of...
8.
Spiess P, Tuziak T, Tibbs R, Bassett R, Tamboli P, Brown G, et al.
Hum Pathol
. 2007 Feb;
38(5):753-61.
PMID: 17306332
Pseudosarcomatous fibromyxoid tumor (PFT), postoperative spindle cell nodule (PSN), sarcoma, and sarcomatoid carcinoma of the bladder are frequently difficult to distinguish histopathologically with significant differences in disease-related outcomes. A retrospective...
9.
Kim J, Tuziak T, Hu L, Wang Z, Bondaruk J, Kim M, et al.
Lab Invest
. 2005 Mar;
85(4):532-49.
PMID: 15778693
Bladder cancer develops in the urothelial lining from intraurothelial preneoplasia via two pathways, papillary and nonpapillary, which correspond to nonaggressive and aggressive forms of the disease. Because these two forms...